Alzheimer Disease

• EMA safety_alert · 2025-05-23
  EMA starts review of ipidacrine-containing medicines

  EMA has started a review of medicines containing ipidacrine to evaluate their effectiveness for authorised uses and to assess potential live…

• CLINICAL_TRIALS safety_alert · 2014-03-20
  Clinical Trial Update: Inappropriate Medications Associated With Anticholinesterase and/or Memantine Treatment in the Elderly

  A clinical trial update highlighting inappropriate prescribing among elderly patients treated with acetylcholinesterase inhibitors and/or me…

• CLINICAL_TRIALS safety_alert · 2011-09-02
  Clinical Trial Update: A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate Alzheimer's Disease Who Participated in the M06-876 Study [Phase 2]

  A Phase 2 study evaluating the long-term safety of ABT-089 in patients with mild-to-moderate Alzheimer's disease who participated in the M06…